138 related articles for article (PubMed ID: 15991530)
21. [Role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 with concurrent HPV infection].
Jach R; Basta A; Szczudrawa A
Ginekol Pol; 2003 Sep; 74(9):729-35. PubMed ID: 14674116
[TBL] [Abstract][Full Text] [Related]
22. Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection.
Romney SL; Ho GY; Palan PR; Basu J; Kadish AS; Klein S; Mikhail M; Hagan RJ; Chang CJ; Burk RD
Gynecol Oncol; 1997 Jun; 65(3):483-92. PubMed ID: 9190980
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of patients treated with recombinant human interferon gamma for cervical intraepithelial neoplasia.
Sikorski M; Zrubek H
Int J Gynaecol Obstet; 2003 Aug; 82(2):179-85. PubMed ID: 12873779
[TBL] [Abstract][Full Text] [Related]
24. Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia.
Morris HH; Gatter KC; Sykes G; Casemore V; Mason DY
Br J Obstet Gynaecol; 1983 May; 90(5):412-20. PubMed ID: 6303384
[TBL] [Abstract][Full Text] [Related]
25. Langerhans cells in human papillomavirus (HPV) lesions of the uterine cervix identified by the monoclonal antibody OKT-6.
Väyrynen M; Syrjänen K; Mäntyjärvi R; Castrén O; Saarikoski S
Int J Gynaecol Obstet; 1984 Oct; 22(5):375-83. PubMed ID: 6151923
[TBL] [Abstract][Full Text] [Related]
26. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.
Da Silva DM; Woodham AW; Skeate JG; Rijkee LK; Taylor JR; Brand HE; Muderspach LI; Roman LD; Yessaian AA; Pham HQ; Matsuo K; Lin YG; McKee GM; Salazar AM; Kast WM
Clin Immunol; 2015 Dec; 161(2):197-208. PubMed ID: 26360252
[TBL] [Abstract][Full Text] [Related]
27. Intralesional beta-interferon treatment of cervical intraepithelial neoplasia associated with human papillomavirus infection.
Penna C; Fallani MG; Gordigiani R; Sonni L; Taddei GL; Marchionni M
Tumori; 1994 Apr; 80(2):146-50. PubMed ID: 8016908
[TBL] [Abstract][Full Text] [Related]
28. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Langerhans' cells in human papillomavirus-associated squamous intraepithelial lesions of the uterine cervix.
Uchimura NS; Ribalta JC; Focchi J; Simões MJ; Uchimura TT; Silva ES
Clin Exp Obstet Gynecol; 2004; 31(4):260-2. PubMed ID: 15672959
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol.
Crum CP; Beach KJ; Hedley ML; Yuan L; Lee KR; Wright TC; Urban RG
J Infect Dis; 2004 Apr; 189(8):1348-54. PubMed ID: 15073670
[TBL] [Abstract][Full Text] [Related]
31. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.
Hallez S; Simon P; Maudoux F; Doyen J; Noël JC; Beliard A; Capelle X; Buxant F; Fayt I; Lagrost AC; Hubert P; Gerday C; Burny A; Boniver J; Foidart JM; Delvenne P; Jacobs N
Cancer Immunol Immunother; 2004 Jul; 53(7):642-50. PubMed ID: 14985860
[TBL] [Abstract][Full Text] [Related]
33. Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia.
Hawthorn RJ; Murdoch JB; MacLean AB; MacKie RM
BMJ; 1988 Sep; 297(6649):643-6. PubMed ID: 2846100
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
[TBL] [Abstract][Full Text] [Related]
35. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
Jeffers MD; Richmond J; Farquharson M; McNicol AM
J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
[TBL] [Abstract][Full Text] [Related]
36. A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.
Park YC; Ouh YT; Sung MH; Park HG; Kim TJ; Cho CH; Park JS; Lee JK
J Gynecol Oncol; 2019 Nov; 30(6):e88. PubMed ID: 31576684
[TBL] [Abstract][Full Text] [Related]
37. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
38. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
[TBL] [Abstract][Full Text] [Related]
39. Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection.
Spinillo A; Tenti P; Zappatore R; De Seta F; Silini E; Guaschino S
Gynecol Oncol; 1993 Feb; 48(2):210-3. PubMed ID: 8381376
[TBL] [Abstract][Full Text] [Related]
40. Interferons and their receptors in human papillomavirus lesions of the uterine cervix.
Cintorino M; Tripodi SA; Romagnoli R; Ietta F; Ricci MG; Paulesu L
Eur J Gynaecol Oncol; 2002; 23(2):145-50. PubMed ID: 12013113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
